Get started

Markets

EUR/GBP – Trendline Break & Retest: Reversal Confirmed?Technical Outlook: EUR/GBP has broken above the descending trendline and is now retesting it from above near 0.8540–0.8560. This zone is critical — holding it confirms a trend reversal. If successful, the next upside targets are 0.8625 and 0.8680. RSI remains above 50, and MACD continues to support bullish momentum. Fundamentals: Dovish expectations from the BoE weigh on the pound. The euro gains support from improving inflation outlook and capital inflows. Interest rate differentials now favor EUR. Scenarios: 📈 Main: bounce from 0.8540–0.8560 → move to 0.8625 and 0.8680 📉 Alt: break below 0.8540 → retracement to 0.8500–0.8480
Long
by TotoshkaTrades
Another market manipulation. It is spiraling out of control!I’m not here to express political opinions, but let’s be real—the Trump family launching meme coins, rugging retail investors, and manipulating markets is spiraling out of control. 💥 $TRUMP and $MELANIA were just the beginning. Today, we witnessed what could be the biggest market manipulation in history, and it was executed with textbook precision: Step one: float a fake news headline to test the market reaction. Step two: publish a deliberately confusing statement where Trump says everything and its opposite. Many misunderstood it as a “90-day tariff pause.” 🕛 The timing? The announcement dropped at 12:30 PM EST—midnight in Asia, and 7 PM in Europe, when banks and institutions were closed. 🎯 Only the U.S. was awake and able to buy the pump. Everyone else? Left sidelined. No politician in modern history has manipulated global markets to this extent. It’s turning Wall Street into a Las Vegas casino for the elite. To make matters worse, Trump even tweeted a sarcastic: “It’s a great day to buy stocks.” 🧨 Reality check: He lowered current tariffs by just 10% Hit China with a massive 125% tariff Recession risk? Still on the table Economic uncertainty? Worse than ever You think China will just let this slide? Retaliation is coming. What we're seeing is a nation burning its credibility while recklessly using financial power to create chaos. 🚨 If you think your money is safe in markets run by these people, think again. This isn't trading anymore—it's Russian Roulette. Markets needs stability. DYOR
BITSTAMP:BTCUSD
by CryptoNikkoid
12
BTC 3D Market BreakdownBitcoin is currently trading around $79,200 on the 3-day chart and is sitting just above the key 0.5 Fibonacci retracement level from its most recent macro impulse. The chart shows a clear descending trendline acting as dynamic resistance, reinforcing the ongoing downward pressure on price. Until this trendline is broken and retested from above, market structure remains bearish in the mid-term. After a strong rally to $108K, BTC was rejected near the 0.25 Fibonacci level at $93K. Since then, it’s formed a series of lower highs, confirming that bulls are losing momentum. The 0.385 retracement level, which aligns with the $85K region, has now acted as resistance multiple times, indicating a strong ceiling unless volume and price action shift. Price is now hovering above the 0.5 retracement area (~$78K–$79K). If this zone fails to hold, Bitcoin is likely headed toward the 0.618 Fib level near $73,747. This level also aligns with the previous all-time high from November 2021, adding to its historical importance. While some buyers may attempt to defend that level for a short-term bounce, the real macro demand lies lower. The green zone around GETTEX:64K to $61K is the highest confluence support area. It matches both the 0.75 and 0.785 Fibonacci retracement levels, and overlaps with the major accumulation and breakout structure from Q4 of 2024. If BTC trades down into that region, it would present a much higher probability bounce zone and a potential macro higher low — if bulls can defend it. Until Bitcoin flips the descending trendline and reclaims $85K with conviction, the market structure favors downside continuation. A reclaim of $85K would be a significant signal for bullish momentum to return, especially if it comes with a breakout retest of the trendline. For now, however, the path of least resistance remains to the downside, with $69K and then GETTEX:64K –$61K as the next key support zones to watch. In summary, Bitcoin remains in a corrective structure beneath its trendline. A move into $69K may offer a reaction, but the most meaningful support lies in the GETTEX:64K –$61K macro zone. Patience is key here, as buyers wait for either deeper value or a clear shift in trend.
by Blast910
Will the Fear Gauge Flash Red?The Cboe Volatility Index (VIX), Wall Street's closely watched "fear gauge," is poised for a potential surge due to US President Donald Trump's assertive policy agenda. This article examines the confluence of factors, primarily Trump's planned tariffs and escalating geopolitical tensions, that are likely to inject significant uncertainty into the financial markets. Historically, the VIX has proven to be a reliable indicator of investor anxiety, spiking during economic and political instability periods. The current climate, marked by a potential trade war and heightened international risks, suggests a strong likelihood of increased market volatility and a corresponding rise in the VIX. President Trump's impending "Liberation Day" tariffs, set to target all countries with reciprocal duties, have already sparked considerable concern among economists and financial institutions. Experts at Goldman Sachs and J.P. Morgan predict that these tariffs will lead to higher inflation, slower economic growth, and an elevated risk of recession in the US. The sheer scale and breadth of these tariffs, affecting major trading partners and critical industries, create an environment of unpredictability that unsettles investors and compels them to seek protection against potential market downturns, a dynamic that typically drives the VIX upward. Adding to the market's unease are the growing geopolitical fault lines involving the US and both China and Iran. Trade disputes and strategic rivalry with China, coupled with President Trump's confrontational stance and threats of military action against Iran over its nuclear program, contribute significantly to global instability. These high-stakes international situations, fraught with the potential for escalation, naturally trigger investor anxiety and a flight to safety, further fueling expectations of increased market volatility as measured by the VIX. In conclusion, the combination of President Trump's aggressive trade policies and the mounting geopolitical risks presents a compelling case for a significant rise in the VIX. Market analysts have already observed this trend, and historical patterns during similar periods of uncertainty reinforce the expectation of heightened volatility. As investors grapple with the potential economic fallout from tariffs and the dangers of international conflicts, the VIX will likely serve as a crucial barometer, reflecting the increasing fear and uncertainty permeating the financial landscape.
CBOE:VIXLong
by UDIS_View
Is Erdogan’s Gambit Destabilizing Turkey’s Future?Erdogan’s administration continues to engage in high-stakes geopolitical maneuvers by maintaining direct and indirect ties with groups designated as terrorist organizations. His government’s strategic alliances, notably with Hayat Tahrir al-Sham (HTS), serve immediate military and political goals in Syria, despite significant international controversy and longstanding terrorist designations by the U.S. and other global actors. This risky strategy has had a pronounced impact on the Turkish economy. Investors have increasingly shifted their capital from the Turkish Lira to the U.S. dollar, leading to a notable rise in the USD/TRY rate. Fears of further economic isolation and the looming threat of sanctions—which could cut off Turkey from critical European banking and trade services—have only intensified market instability. The growing strains within NATO and shifting regional alliances are compounding these economic challenges. Erdogan’s pragmatic yet contentious foreign policy raises serious questions about Turkey’s future role within the alliance, as Western partners deliberate potential sanctions and other measures. Meanwhile, evolving dynamics with regional powers such as Russia and Iran add further uncertainty to Turkey’s strategic position and economic prospects.
Long
by UDIS_View
General Market Ramblings - $BTCUSD, $TSLA, $GDX, $DAL, $BBEUHi, all. Wanted to get something published for the first time in awhile. Unfortunately my mom passed away recently and that has been something I have been going through. It is therapeutic to record something and get it out to you all. I am approaching feature film length on this one, so kudos if you make it through the whole video. I just wanted to discuss some general market thoughts here - especially as we are now in an interesting time. I hope you do find some value here! Believe me, this really is just scratching the surface of my market thoughts and the different stocks that I have thoughts on. But again, really just wanted to get something out to you guys. Even if you tune in for a minute or two, thanks for watching! It means a lot. Feel free to provide feedback as well of course. As always, a lot of my thoughts are based on the "Time @ Mode" method that we discuss in the Key Hidden Levels TradingView chat. Also, as always, these are strictly my thoughts and opinions. I am not a professional and I encourage you to do your own research before making investment/trading decisions. These opinions are not financial advice. Assets in this video: COINBASE:BTCUSD , COMEX:GC1! , NASDAQ:TSLA , AMEX:GDX , CBOE:BBEU , NYSE:DAL , maybe others I forgot about.
NYSE:DAL
by redykhouse
NN GROUP ($NN) Q4—INSURANCE CASH SHINES IN EUROPENN GROUP ( EURONEXT:NN ) Q4—INSURANCE CASH SHINES IN EUROPE (1/9) Good evening, TradingView! NN Group ( EURONEXT:NN ) is humming—H2 revenue hit $ 7.94B, topping estimates 📈🔥. Q4 earnings and a cash boost spark buzz—let’s unpack this Dutch dynamo! 🚀 (2/9) – REVENUE RUSH • H2 Haul: $ 7.94B—beats $ 7.41B est. 💥 • Full ‘24: $ 12.36B—up 12% from $ 11.03B 📊 • OCG: $ 1.9B—hits ‘25 goal early EURONEXT:NN ’s cash flow’s sizzling—steady wins! (3/9) – BIG MOVES • Buyback: $ 300M—shares get a lift 🌍 • Dividend: $ 3.44—up 8%, juicy payout 🚗 • Deals: $ 360M settled—risks trimmed 🌟 EURONEXT:NN ’s flexing—insurance muscle shines! (4/9) – SECTOR SNAP • P/E: ~10—below 11.9x avg 📈 • P/B: 0.57—vs. sector’s 1.04—cheap? • Edge: 12% growth tops peers 🌍 EURONEXT:NN ’s a bargain—or just quiet strength? (5/9) – RISKS ON DECK • EPS Miss: $ 2.21 vs. $ 3.60—hiccup ⚠️ • Rates: Volatility stings returns 🏛️ • Climate: Claims could climb—yikes 📉 Solid run—can it dodge the bumps? (6/9) – SWOT: STRENGTHS • Cash: $ 1.9B OCG—rock solid 🌟 • Payouts: 8% divvy, $ 300M buyback 🔍 • Europe: 20% new biz—growth zip 🚦 EURONEXT:NN ’s a steady beast—built tough! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: EPS slip, Dutch lean 💸 • Opportunities: Eastern Europe perks 🌍 Can EURONEXT:NN zap past the risks? (8/9) – EURONEXT:NN ’s Q4 cash surge—what’s your vibe? 1️⃣ Bullish—Value shines bright. 2️⃣ Neutral—Solid, risks hover. 3️⃣ Bearish—Misses stall it out. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY EURONEXT:NN ’s $ 7.94B H2 and $ 1.9B OCG spark zing—insurance hums 🌍. Low P/E, but EPS wobbles—gem or pause?
EURONEXT:NNLong
by DCAChampion
BERKSHIRE HATHAWAY ($BRK.A) Q4—INSURANCE & CASH SHINEBERKSHIRE HATHAWAY ( NYSE:BRK.A ) Q4—INSURANCE & CASH SHINE (1/9) Good afternoon, TradingView! Berkshire Hathaway ( NYSE:BRK.A ) is humming—Q4 operating earnings soared 71% to $ 14.5B 📈🔥. Insurance and a record cash pile spark buzz—let’s unpack this titan! 🚀 (2/9) – EARNINGS SURGE • Q4 Ops: $ 14.5B—up from $ 8.5B last year 💥 • Full ‘24: Insurance jumps 51%—key driver 📊 • Net: $ 19.7B Q4—profit stays juicy NYSE:BRK.A ’s flexing—steady as she goes! (3/9) – BIG MOVES • Cash Hoard: $ 334B—up from $ 270B mid-year 🌍 • No Buybacks: Q4 skips—$ 7B spent earlier 🚗 • Apple Trim: Half sold off—cash king 🌟 Buffett’s stacking bucks—ready for action! (4/9) – SECTOR SNAP • Market Cap: ~$ 1.075T—top tier 📈 • P/B: 1.55—vs. JPM’s 1.9, Allstate’s 1.3 • Outrun: 25.5% ‘24 vs. S&P’s 25% 🌍 NYSE:BRK.A ’s a beast—value or peak? (5/9) – RISKS IN SIGHT • Stocks: Apple, Chevron swings—volatility nips ⚠️ • Succession: Buffett’s exit looms—jitters? 🏛️ • Economy: Rail, retail soften if cash tightens 📉 Solid, but not ironclad—watch out! (6/9) – SWOT: STRENGTHS • Diverse: Insurance leads—51% growth 🌟 • Cash: $ 334B—ultimate cushion 🔍 • Track: 19.8% CAGR—beats S&P’s 10.2% 🚦 NYSE:BRK.A ’s a fortress—built tough! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: Insurance lean, cash sits 💸 • Opportunities: Deals, yields lift—$ 14.5B zing 🌍 Can NYSE:BRK.A zap the next big win? (8/9) – NYSE:BRK.A ’s Q4 surge—what’s your vibe? 1️⃣ Bullish—Cash rules, value shines. 2️⃣ Neutral—Solid, risks balance. 3️⃣ Bearish—Growth stalls, succession bites. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY NYSE:BRK.A ’s $ 14.5B Q4 and $ 334B cash spark zing—insurance flexes 🌍. Premium P/B, but steady wins—champ or chill?
NYSE:BRK.ALong
by DCAChampion
ARISTA NETWORKS ($ANET) ZAPS Q4—AI & CLOUD FUEL SURGEARISTA NETWORKS ( NYSE:ANET ) ZAPS Q4—AI & CLOUD FUEL SURGE (1/9) Good evening, TradingView! Arista Networks ( NYSE:ANET ) is buzzing—$ 7B in 2024 revenue, up 19.5% 📈🔥. Q4 shines with AI and cloud demand—let’s unpack this tech titan! 🚀 (2/9) – REVENUE RUSH • 2024 Haul: $ 7B—19.5% jump from $ 5.86B 💥 • Q4 Take: $ 1.93B—25.3% up, beats $ 1.9B 📊 • EPS: $ 0.65—tops $ 0.57, up 25% NYSE:ANET ’s humming—cloud’s got juice! (3/9) – BIG PLAYS • Q1 ‘25 Guide: 1.93 − 1.97B—above $ 1.907B 🌍 • Stock Split: 4-for-1—shares for all! 🚗 • AI Ties: Meta, NVIDIA deals spark buzz 🌟 NYSE:ANET ’s wiring the future—full throttle! (4/9) – SECTOR SNAP • P/E: ~54—premium vs. Cisco’s 17 📈 • Growth: 19.5% smokes sector’s 7% • Edge: 70-80% Microsoft share—kingpin 🌍 NYSE:ANET ’s hot—value or stretch? (5/9) – RISKS IN VIEW • Clients: Microsoft, Meta—big eggs, one basket ⚠️ • Comp: Cisco bites back—AI race heats 🏛️ • Economy: Capex cuts could sting 📉 High flyer—can it dodge the turbulence? (6/9) – SWOT: STRENGTHS • AI Lead: $ 750M ‘25 target—cloud king 🌟 • Margins: 64.6%—profit punch 🔍 • Cash: 95% flow jump, no debt 🚦 NYSE:ANET ’s a lean, mean machine! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: Client lean, high P/E 💸 • Opportunities: AI clusters, enterprise zip 🌍 Can NYSE:ANET zap past the risks? (8/9) – NYSE:ANET ’s Q4 buzz—what’s your vibe? 1️⃣ Bullish—AI keeps it soaring. 2️⃣ Neutral—Growth’s solid, risks linger. 3️⃣ Bearish—Premium fades fast. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY NYSE:ANET ’s $ 1.93B Q4 and AI deals spark zing—$ 7B year shines 🌍. Premium P/E, but growth rules—champ or chase?
NYSE:ANETLong
by DCAChampion
1
$DXY HOLDS FIRM—TRUMP TARIFFS & FED FUEL 2025 BUZZTVC:DXY HOLDS FIRM—TRUMP TARIFFS & FED FUEL 2025 BUZZ (1/9) Good afternoon, Tradingview! The U.S. Dollar Index ( TVC:DXY ) sits at 106.47 today—tariffs and Fed vibes keep it humming 📈🔥. Down a hair from 106.60—let’s unpack this greenback glow! 🚀 (2/9) – YEARLY SURGE • 2024 Run: From 100.16 to 107+ by Dec 💥 • Today: 106.47—off 0.12% from yesterday 📊 • Driver: Trump tariffs juice inflation fears TVC:DXY ’s got grit—2025’s off to a zesty start! (3/9) – BIG BOOSTERS • Tariffs: Auto, chip threats—dollar darling 🌍 • Fed: Slow cuts—rates outshine abroad 🚗 • Crypto Nod: Pro- AMEX:USD admin vibes 🌟 Greenback’s flexing—policy packs a punch! (4/9) – MARKET PULSE • Vs. Peers: Outpaces euro, yen—rate gaps shine 📈 • X Chatter: 107 peak, post-swearing dip? • Edge: U.S. growth trumps global woes 🌍 TVC:DXY ’s steady—king of the currency hill? (5/9) – RISKS IN PLAY • Deficits: Fiscal bloat looms long-term ⚠️ • Geo-Tension: Wars nudge safe-haven bets 🏛️ • Fed Pivot: Faster cuts could dim shine 📉 Tough tailwinds—can TVC:DXY dodge the drag? (6/9) – SWOT: STRENGTHS • Tariffs: Inflation lift—dollar darling 🌟 • Rates: Fed’s edge over ECB, BOJ 🔍 • Haven: Chaos loves $ USD—rock solid 🚦 TVC:DXY ’s got muscle—global star! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: Debt piles—future wobble? 💸 • Opportunities: Tariff hikes zap rivals 🌍 Can TVC:DXY keep the crown or stumble? (8/9) – TVC:DXY at 106.47—what’s your vibe? 1️⃣ Bullish—108+ by spring. 2️⃣ Neutral—Holds steady, risks hover. 3️⃣ Bearish—Dips below 100 soon. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY TVC:DXY ’s 106.47 glow—tariffs, Fed, and grit shine 🌍🪙. Deficits lurk, but strength rules—bull or bust?
TVC:DXYLong
by DCAChampion
MERCADOLIBRE ($MELI) SOARS IN Q4—E-COMMERCE & FINTECH SHINE MERCADOLIBRE ( NASDAQ:MELI ) SOARS IN Q4—E-COMMERCE & FINTECH SHINE (1/9) Good evening, Tradingview! MercadoLibre ( NASDAQ:MELI ) is sizzling—Q4 revenue up 37%, a $ 6.1B haul 📈🔥. Fintech and e-commerce fuel a 33% surge—let’s unpack this Latin dynamo! 🚀 (2/9) – REVENUE RUSH • Q4 Take: $ 6.1B—37% leap, tops $ 5.9B est. 💥 • EPS: $ 12.61—blasts past $ 7.94 hopes 📊 • Net Income: $ 639M—beats $ 402M dreams NASDAQ:MELI ’s humming—growth’s got zing! (3/9) – BIG MOVES • GMV: $ 14.5B—56% jump FX-neutral 🌍 • Payments: $ 58.9B TPV—49% up 🚗 • Credit Boom: $ 6.6B—74% growth 🌟 NASDAQ:MELI ’s flexing muscle—full throttle! (4/9) – MARKET VIBE • P/E: ~60—above Amazon’s 40, PDD’s 20 📈 • Growth: 37% smokes peers’ 10% • Targets: 2,400−3,000—10-38% upside 🌍 Premium price—worth the juice? (5/9) – RISKS ON DECK • FX Woes: Brazil, Mexico currencies wobble ⚠️ • Comp: Amazon, locals eye the prize 🏛️ • Rates: $ 6.6B credit—defaults lurk? 📉 Hot run—can it dodge the heat? (6/9) – SWOT: STRENGTHS • E-comm: $ 14.5B GMV—LatAm king 🌟 • Fintech: $ 58.9B TPV—Pago’s gold 🔍 • Logistics: 6 new centers—zippy edge 🚦📉 NASDAQ:MELI ’s a double-threat dynamo! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: High P/E, FX swings 💸 • Opportunities: Ad bucks, untapped markets 🌍 Can NASDAQ:MELI zap past the bumps? (8/9) – NASDAQ:MELI ’s Q4 surge—what’s your vibe? 1️⃣ Bullish—$ 3,000 in sight. 2️⃣ Neutral—Growth’s hot, risks hover. 3️⃣ Bearish—FX bites back. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY NASDAQ:MELI ’s $ 6.1B Q4 and fintech flex spark buzz—$ 14.5B GMV shines 🌍🪙. High P/E, but growth rules—champ or chase?
NASDAQ:MELI
by DCAChampion
VERTEX ($VRTX) SHINES IN Q4—PAIN & CF FUEL GROWTHVERTEX ( NASDAQ:VRTX ) SHINES IN Q4—PAIN & CF FUEL GROWTH (1/9) Good evening, Tradingview! Vertex ( NASDAQ:VRTX ) is buzzing—Q4 revenue up 16%, new drugs hit the scene 📈🔥. $ 2.91B and a bold 2025 forecast—let’s unpack this biotech beast! 🚀 (2/9) – REVENUE RUSH • Q4 Haul: $ 2.91B—16% jump from last year 💥 • Full ‘24: $ 11.02B, up 12%—Trikafta’s king 📊 • ‘25 Outlook: $11.75-$ 12B—6-9% growth NYSE:CF keeps humming—newbies add zest! (3/9) – BIG WINS • Journavx: Non-opioid painkiller greenlit Jan ‘25 🌍 • Alyftrek: CF drug for 6+—ships now 🚗 • Cash: $11.2B—loaded for action 🌟 NASDAQ:VRTX storms pain—CF stays golden! (4/9) – SECTOR CHECK • Valuation: 11x sales—above 9x avg 📈 • Vs. Peers: Gilead’s 4x, Regeneron’s 8x—premium? • Growth: 12% beats biotech’s 5-7% 🌍 NASDAQ:VRTX flexes—value or stretch? (5/9) – RISKS ON TAP • Payers: Journavx needs coverage—hiccups? ⚠️ • Trikafta: 93% of sales—big lean 🏛️ • Comp: Pain rivals, CF safe—for now 📉 Hot streak—can it dodge the bumps? (6/9) – SWOT: STRENGTHS • CF King: Trikafta, Alyftrek lock it in 🌟 • Pain Play: Journavx eyes $ 4B peak 🔍 • Cash: $11.2B—war chest ready 🚦 NASDAQ:VRTX ’s got muscle and moolah! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: Trikafta reliance—eggs in one basket 💸 • Opportunities: Casgevy rolls, pain grows 🌍 Can NASDAQ:VRTX zap past the risks? (8/9) – NASDAQ:VRTX ’s Q4 surge—what’s your vibe? 1️⃣ Bullish—Pain pays off big. 2️⃣ Neutral—Solid, but risks linger. 3️⃣ Bearish—Growth hits a wall. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY NASDAQ:VRTX ’s $2.91B Q4 and Journavx/Alyftrek wins spark buzz—$11.2B cash backs it 🌍🪙. Trikafta rules, risks hover—champ or chaser?
NASDAQ:VRTXLong
by DCAChampion
CELSIUS ($CELH) ZAPS UP 33%—Q4 & ALANI NU IGNITE BUZZCELSIUS ( NASDAQ:CELH ) ZAPS UP 33%—Q4 & ALANI NU IGNITE BUZZ (1/9) Good evening, Tradingview! Celsius Holdings ( NASDAQ:CELH ) just surged 33%—Q4 earnings and a $1.65B Alani Nu buyout lit the fuse 📈🔥. Energy drink market’s buzzing—let’s unpack this jolt! 🚀 (2/9) – EARNINGS SNAP • Q4 Revenue: $332M, topped $329M expected 💥 • Margin: Jumped to 50.2%—beats 47.1% hopes 📊 • EPS: $0.14, above $0.11—solid grit Growth slowed, but NASDAQ:CELH flexed resilience! (3/9) – ALANI NU DEAL • Price: $1.65B—$1.275B cash, $500M stock 🌍 • Alani’s Pull: $595M ‘24 sales, 78% growth 🚗 • Combo: 16% energy drink share—$ 2B ‘25 goal 🌟 NASDAQ:CELH snags a rival—big playtime! (4/9) – MARKET VIBE • Surge: 33% to $33-$35—shorts burned 📈 • Vs. Peers: 6x sales, below 9x avg—value? • X Hype: “Top gainer”—bulls cheer 🌍 NASDAQ:CELH heats up—bargain or buzz? (5/9) – RISKS IN SIGHT • Overlap: Alani vs. CELH—cannibal clash? ⚠️ • Slowdown: North Am. down 6%—Pepsi hiccups 🏛️ • Comp: Rivals eye shelf space—tight race 📉 Hot move, but bumps lurk ahead! (6/9) – SWOT: STRENGTHS • Deal: $1.65B Alani—growth rocket 🌟 • Margin: 50.2%—profit punch 🔍 • Global: 39% intl. leap—worldwide zip 🚦 NASDAQ:CELH ’s firing on all cylinders! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: Q4 dip, overlap risks 💸 • Opportunities: $ 2B sales, $50M synergies 🌍 Can NASDAQ:CELH juice up the doubters? (8/9) – NASDAQ:CELH ’s 33% zap—what’s your vibe? 1️⃣ Bullish—$40+ in sight. 2️⃣ Neutral—Growth’s cool, risks hover. 3️⃣ Bearish—Hype fades fast. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY NASDAQ:CELH ’s Q4 and Alani Nu deal spark a 33% leap—$332M, $1.65B buy 🌍🪙. Resilience shines, but overlap looms—champ or chase?
NASDAQ:CELHLong
by DCAChampion
ETHEREUM’S 2025—$ETH POWERS UP WITH ETFs & DEFIETHEREUM’S 2025— CRYPTOCAP:ETH POWERS UP WITH ETFs & DEFI (1/9) Good morning, Tradingview! Ethereum’s flexing muscle—ETFs and DeFi keep CRYPTOCAP:ETH humming 📈🔥. Institutional cash and altcoin grit shine—let’s unpack this crypto king! 🚀 (2/9) – ETF BUZZ • Inflows: $SEED_TVCODER77_ETHBTCDATA:3B+ into ETH ETFs since July ‘24 💥 • Feb Surge: $500M+ in a week—BlackRock leads 📊 • Outlook: $10-15B by year-end? Big players bet big— CRYPTOCAP:ETH ’s got juice! (3/9) – DEFI DOMINANCE • TVL: $120B locked in Feb ‘25—up from $78B 🌍 • Share: 60%+ of DeFi’s action 🚗 • Goal: $200B by Dec? Steno says maybe 🌟 Ethereum’s the DeFi backbone—unshaken! (4/9) – ALTCOIN EDGE • Altcoin Cap: $1.6T— CRYPTOCAP:ETH holds 10-12% 📈 • ETH/BTC: Climbing to 0.06—alt season whispers • Vs. BTC: 57% dominance— CRYPTOCAP:ETH stands tall Resilient king—altcoins rally behind! 🌍 (5/9) – RISKS ON RADAR • Regs: Rules could snag ETF, DeFi growth ⚠️ • Rivals: Solana bites at CRYPTOCAP:ETH ’s heels 🏛️ • Price Dip: $2,632—off Jan highs 📉 Solid, but not bulletproof—watch out! (6/9) – SWOT: STRENGTHS • ETFs: $ 3B+ inflows—cash keeps flowing 🌟 • DeFi: $120B TVL—ecosystem champ 🔍 • Stake: 54M+ ETH locked—rock steady 🚦 CRYPTOCAP:ETH ’s the muscle in crypto town! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: $ 2,632 lags inflows—sentiment lags 💸 • Opportunities: $ 200B TVL, Pectra lifts 🌍 Can CRYPTOCAP:ETH zap to new heights? (8/9) – CRYPTOCAP:ETH ’s ETF & DeFi run—what’s your vibe? 1️⃣ Bullish—King keeps ruling. 2️⃣ Neutral—Growth’s cool, risks hover. 3️⃣ Bearish—Rivals steal the crown. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY CRYPTOCAP:ETH ’s humming—$ 3B ETFs, $120B DeFi, altcoin grit 🌍. $ 200B TVL in sight, but rivals lurk. Champ or challenger?
BINANCE:ETHUSDLong
by DCAChampion
$US30 DOW JONES—STEADY AMID THE STORMDOW JONES—STEADY AMID THE STORM (1/9) Good morning, Tradingview! The Dow Jones is the cool-headed cousin—less wild than Nasdaq’s growth party 📈🔥. Blue-chip stability shines, even as inflation bites—let’s unpack it! 🚀 (2/9) – WHY SO CALM? • Makeup: 30 big, steady names—Walmart, Goldman 💥 • Price-Weighted: High flyers lead, not tech zingers 📊 • Edge: Less sway from growth stock swings Dow’s the tortoise—slow and steady wins? (3/9) – RECENT VIBES • Feb 22: 1.7% dip—support at 43,400 holds 🌍 • VIX: Stays chill—Nasdaq would’ve freaked 🚗 • CPI Hit: 400-point drop, 300 back—meh 🌟 Stability’s the Dow’s secret sauce! (4/9) – SECTOR SNAP • Vs. Nasdaq: Tech’s jittery—Dow’s diversified 📈 • Volatility: ~15-20% vs. Nasdaq’s 25-30% • Champs: Blue-chips buffer the chaos Steadier ship—less Nasdaq nuttiness! 🌍 (5/9) – INFLATION RIPPLES • CPI Spike: 3% YoY—400-point jolt ⚠️ • Fed: No rush to cut—rates sting 🏛️ • X Buzz: Tariffs, inflation spook recovery 📉 Even the Dow feels the heat—but shrugs! (6/9) – SWOT: STRENGTHS • Stability: Blue-chip backbone holds firm 🌟 • Dividends: Cash flows steady the ship 🔍 • Mix: Less tech tantrums—broad base 🚦 Dow’s the rock in choppy waters! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: Inflation nicks costs—ouch 💸 • Opportunities: Safety shines if tech flops 🌍 Can Dow dodge the inflation blues? (8/9) – Dow’s steady play—what’s your vibe? 1️⃣ Bullish—Stability’s golden. 2️⃣ Neutral—Holds, but inflation looms. 3️⃣ Bearish—Growth wins anyway. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY Dow’s less jittery—blue-chips cushion the storm 🌍🪙. Inflation’s a nag, but stability rules. Rock or relic?
ICMARKETS:US30Long
by DCAChampion
EURO LIFTS POST-GERMAN VOTE—BUT USD BITES BACKEURO LIFTS POST-GERMAN VOTE—BUT USD BITES BACK FX:EURUSD (1/9) Good morning, Tradingview Fam! Germany’s election—Merz and CDU on top—gave the euro a quick jolt, up 0.44% to $1.0507 📈🔥. Markets dig the stability vibe, but it’s fading fast—let’s unpack this tussle! 🚀 (2/9) – ELECTION SPARK • Euro Bump: Hit $1.0530 overnight—election cheer 💥 • Markets: DAX futures up 1.2%, EUROSTOXX 50 +0.66% 📊 • Fade: Now at $1.0480—USD’s flexing back Brief lift—stability’s sweet, but not sticky! (3/9) – TECH TELLTALE • Resistance: $1.0500-1.0510 wall holds firm 🌍 • Support: $1.0470 pivot, then $1.0440 if it slips 🚗 • Charts: Double top whispers at $1.0530 🌟 Traders on X see a retreat—bearish juice brewing? (4/9) – USD PUSHBACK • Jobless Claims: Weak last week, USD softened a tad 📉 • Fed: No rush to cut—rates steady, Nvidia looms • Muscle: Dollar’s clawing back—ballast holds AMEX:USD ’s got grit—euro’s nudge ain’t enough! 🌍 (5/9) – RISKS IN PLAY • Volatility: PMI data, Nvidia earnings stir the pot ⚠️ • Sentiment: X split—liquidity grab or bear turn? 🏛️ • Levels: Below $1.0470 opens $1.0390 risk 📉 Quick sprint—can euro keep the pace? (6/9) – SWOT: STRENGTHS • Election Lift: CDU win sparks euro hope 🌟 • Markets: European futures pop—optimism flows 🔍 • Cash: $1.0530 peak shows buyer guts 🚦 Euro’s got some spark—briefly lit! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: $1.0510 cap, USD fights back 💸 • Opportunities: PMI beats could push $1.0600 🌍 Will euro dodge the dollar’s jab? (8/9) – Euro’s election bump—what’s your call? 1️⃣ Bullish—Stability wins out. 2️⃣ Neutral—Blip, not a trend. 3️⃣ Bearish—USD takes the ring. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY Euro spiked to $1.0507 on Germany’s vote—CDU’s steady hand 🌍🪙. Now $1.0480—USD’s got claws. Resistance bites, downside looms—blip or bust?
by DCAChampion
SOLID BIOSCIENCES—$SLDB CASHES UP FOR GENE THERAPY PUSHSOLID BIOSCIENCES— NASDAQ:SLDB CASHES UP FOR GENE THERAPY PUSH (1/9) Good afternoon, Tradingview! Solid Biosciences is stacking cash—no revenue yet, but a $200M raise has tongues wagging 📈🔥. NASDAQ:SLDB ’s betting big on gene therapy—here’s the scoop! 🚀 (2/9) – CASH, NOT SALES • Revenue: Zilch—clinical-stage vibes 💥 • Q3 ‘24 Loss: $0.61/share, missed $0.58 est. 📊 • Cash Boost: $200M offering just landed No sales, but NASDAQ:SLDB ’s war chest is growing! (3/9) – BIG MOVE • Feb 18 Raise: $200M via 35.7M shares, warrants 🌍 • Cash Pile: Was $171M, now nearing $350M 🚗 • Goal: Fuel SGT-003 trials into ‘27 🌟 NASDAQ:SLDB ’s loading up for the long haul! (4/9) – SECTOR CHECK • Market Cap: $500M post-raise 📈 • Vs. Peers: Sarepta’s 13B dwarfs it—revenue rules • Edge: Low EV ($150M), big therapy dreams Undervalued biotech bet or long shot? 🌍 (5/9) – RISKS ON DECK • Trials: SGT-003 flops could sink it ⚠️ • Sentiment: 30% drop from Jan peak—jitters 🏛️ • Burn: $20-25M/quarter—clock’s ticking 📉 High stakes, high risks—can it deliver? (6/9) – SWOT: STRENGTHS • Cash: $200M raise powers trials 🌟 • SGT-003: Early data dazzles, Fast Track nod 🔍 • DMD Focus: Huge need, blockbuster shot 🚦 NASDAQ:SLDB ’s got fuel and firepower! (7/9) – SWOT: WEAKNESSES & OPPORTUNITIES • Weaknesses: No revenue, all-in on one play 💸 • Opportunities: $2-4B cap if trials pop 🌍 Can NASDAQ:SLDB turn cash into a cure? (8/9) – NASDAQ:SLDB ’s $200M haul—your take? 1️⃣ Bullish—Gene therapy gold ahead. 2️⃣ Neutral—Wait for trial proof. 3️⃣ Bearish—Risks outweigh the buzz. Vote below! 🗳️👇 (9/9) – FINAL TAKEAWAY NASDAQ:SLDB ’s revenue-free, but $200M keeps SGT-003 alive—stock’s buzzing 🌍🪙. Low EV vs. peers, yet trials and rivals loom. Cure or bust?
NASDAQ:SLDBLong
by DCAChampion